http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2006135617-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_36219b2551e5300ce886e9a910e6c3de
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_55154732c60f5a75b652ddc494f5c850
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_96ecff1db2f39f5bec8b9a9c18d7e16d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4b9abf44b30d242e83b9353562e0e6e7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7620694046732f3316817c0b24e1e6ad
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C51-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C211-27
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C51-412
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C51-43
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C51-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-194
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C51-43
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C51-41
filingDate 2004-01-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_55d5e6d898641cb6210c661b0ac4b888
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c064e0774373aeee5f6b4c7ff56fc535
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f7b7ae4dda41d99367e27d08c008c94e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e15db8aa6dcd3f6310f85eadb46f6b98
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fe7da7bfc0abd3725d0ad41fa6be489a
publicationDate 2006-06-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-2006135617-A1
titleOfInvention Process for producing optically active flurbiprofen
abstract The present invention provides a method for producing optically active flurbiprofen. The method of the present invention includes mixing racemic flurbiprofen and (S)- or (R)-3-methyl-2-phenylbutylamine in an organic solvent to produce a diastereomeric salt; and treating the diastereomeric salt with an acid in a second solvent. In the method of the present invention, flurbiprofen having a desired absolute configuration can be obtained very efficiently without repeating the procedure for optical resolution a plurality of times.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11407730-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-113045532-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104478703-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2014045046-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11279685-B2
priorityDate 2003-01-23-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-3959364-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4209638-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5190981-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-3755427-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5599969-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID231189892
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID22292848
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129308098
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID450780035
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7914
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127571610
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129459335
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394759
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226417493
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393755
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226459332
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226417492
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6278
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID230880021
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID67105
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID140262341
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9880217
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID139193060
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129308099
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129308097
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID139193059
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129165959
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID72099
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129459334
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129459333
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11457832
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226597257
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10176271
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID92337
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3394
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7408
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394073
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID160716259
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID142290082
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID402
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID138982780
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID159516181
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129396299
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10249763
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID452479887

Total number of triples: 76.